Huateng Pharma Develpoed Kinds Of Intermediates For Carfilzomib - Labinsights

Huateng Pharma Develpoed Kinds Of Intermediates For Carfilzomib

icon.highlightedarticle.dark Tech & Analysis
56 views Last modified: 8 May 2023
Article image of: Huateng Pharma Develpoed Kinds Of Intermediates For Carfilzomib

Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.

Carfilzomib is derived from epoxomicin, a natural product that was shown by the laboratory of Craig Crews at Yale University to inhibit the proteasome. The Crews laboratory subsequently invented a more specific derivative of epoxomicin named YU101, which was licensed to Proteolix, Inc. Scientists at Proteolix invented a new, distinct compound that had potential use as a drug in humans, known as carfilzomib. Proteolix advanced carfilzomib to multiple Phase 1 and 2 clinical trials, including a pivotal phase 2 clinical trial designed to seek accelerated approval. Clinical trials for carfilzomib continue under Onyx Pharmaceuticals, which acquired Proteolix in 2009.

Carfilzomib covalently irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S proteasome, an enzyme that degrades unwanted cellular proteins. Carfilzomib displays minimal interactions with non-proteasomal targets, thereby improving safety profiles over bortezomib. Inhibition of proteasome-mediated proteolysis results in a build-up of polyubiquitinated proteins, which may cause cell cycle arrest, apoptosis, and inhibition of tumor growth.

Huateng Pharma developed several kinds of intermediates for Carfilzomib with high quality & fast shipping. We are able to provide the services of Anti-Cancer intermediates` process development and scale-up production with capacities varying from gram to kilograms and multi tons.

Today I want to introduce two kinds of intermediates for Carfilzomib from Huateng Pharma.

Product name: 1-​Pentanone,2-​amino-​4-​methyl-​1-​[(2R)​-​2-​methyl-​2-​oxiranyl]​-​,(2S)​-​,2,​2,​2-​trifluoroacetate(1:1)

CAS NO.: 247068-85-5

Catalog ID: 98534

Purity: 98%

Molecular formula: C9H17NO2.C2Hf3O2

Molecular weight: 285.26

Product name: (S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate

CAS NO.: 868539-96-2

Catalog ID: 99702

Purity: 98%

Molecular formula: C31H43N3O6

Molecular weight: 553.696

Meer zien icon.arrow--dark

Written by

Hunan Huateng Pharmaceutical Co. Ltd

Hunan Huateng Pharmaceutical Co., Ltd. was founded in 2013, which is a high-tech company specializing in API intermediates, high-end chemical and biochemical reagents. Huateng is equipped with 5000m2 laboratory and... Read more